Minghao Xu, Lu Diao, Xiangxiang Xu, Ao Zhu, Yu Wang, Mi Liu
{"title":"Proteins from Stressed Mesenchymal Stem Cells Can Repair Hair Follicles and Promote Hair Regeneration.","authors":"Minghao Xu, Lu Diao, Xiangxiang Xu, Ao Zhu, Yu Wang, Mi Liu","doi":"10.1021/acsptsci.5c00184","DOIUrl":null,"url":null,"abstract":"<p><p>Androgenetic alopecia (AGA) is the most prevalent type of hair loss in the clinic. Corticosteroids are the most widely used agents for hair loss treatment. However, the long-term use of hormonal drugs is associated with various side effects. Therefore, new treatment methods are urgently needed. In this study, we found that proteins derived from stressed mesenchymal stem cells (PDSSCs) can be utilized to treat AGA in a mouse model. Secretion from chemically stimulated mesenchymal stem cells (MSCs) can reverse hair loss through immune regulation and anti-inflammatory functions. Herein, the root extract of Atalantia monophylla is utilized to stimulate MSCs to produce stress proteins with immunomodulatory function, and thus, proteins derived from stressed MSCs (PDSSCs) can be obtained from stimulated MSCs. We found that PDSSCs successfully boosted hair growth and activated hair follicle (HF) stem cells, thereby inducing hair regeneration in an AGA mouse model. PDSSCs achieved this effect through the Wnt pathway and the TGF-β pathway. Our research is the first to illustrate that stressed-MSC therapy can improve hair regeneration in AGA mice. Overall, this study demonstrated that utilizing PDSSCs from MSCs stimulated with the root extract of Atalantia monophylla to treat AGA is a promising strategy.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 6","pages":"1768-1777"},"PeriodicalIF":4.9000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171876/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsptsci.5c00184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/13 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Androgenetic alopecia (AGA) is the most prevalent type of hair loss in the clinic. Corticosteroids are the most widely used agents for hair loss treatment. However, the long-term use of hormonal drugs is associated with various side effects. Therefore, new treatment methods are urgently needed. In this study, we found that proteins derived from stressed mesenchymal stem cells (PDSSCs) can be utilized to treat AGA in a mouse model. Secretion from chemically stimulated mesenchymal stem cells (MSCs) can reverse hair loss through immune regulation and anti-inflammatory functions. Herein, the root extract of Atalantia monophylla is utilized to stimulate MSCs to produce stress proteins with immunomodulatory function, and thus, proteins derived from stressed MSCs (PDSSCs) can be obtained from stimulated MSCs. We found that PDSSCs successfully boosted hair growth and activated hair follicle (HF) stem cells, thereby inducing hair regeneration in an AGA mouse model. PDSSCs achieved this effect through the Wnt pathway and the TGF-β pathway. Our research is the first to illustrate that stressed-MSC therapy can improve hair regeneration in AGA mice. Overall, this study demonstrated that utilizing PDSSCs from MSCs stimulated with the root extract of Atalantia monophylla to treat AGA is a promising strategy.
期刊介绍:
ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.
ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.
Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.